Clinical trial
A Prospective Single-arm Phase Ⅱ Study of Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
NCT04844385 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Single-arm Phase Ⅱ Study of Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 20, 2021
- Completion date
- December 20, 2024
- Enrollment
- 124 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.